McKesson, CD&R near $5 billion-plus deal to buy Option Care, FT reports

Drug distributor McKesson and private equity firm Clayton Dubilier & Rice are ​nearing a deal to acquire infusion services provider ‌Option Care Health in a transaction valued at more than $5 billion ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。